The pharmaceutical company and the developer of ChatGPT recently announced their cooperation, thanks to which OpenAI will help automate almost all business processes of the biotechnology company with artificial intelligence, including the testing and development of medicines.
Moderna and OpenAI are teaming up to make it easier to create new products of the biotechnology company in the future. Moderna is most famous for its vaccine for COVID, and as people use it less and less, their revenue has also decreased. The company is trying to create new products, but for this they need artificial intelligence.
According to reports, Moderna’s 3,000 employees this week already had access to ChatGPT Enterprise, based on GPT?4, for AI to facilitate various processes. Examples include the optimization of doses used in clinical trials, searches in huge databases, and logistics. In addition to all of this, artificial intelligence will probably also help the company to discover new active pharmaceutical ingredients in the future.
announced its cooperation, thanks to which OpenAI will help the automation of almost all business processes of the biotechnology company with artificial intelligence, including the testing and development of medicines.’>
